During the past decade, MediOnko-Institut GbR conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "MediOnko-Institut GbR" #1 collaborator was "Austrian Breast & Colorectal Cancer Study Group" with 1 trials as a collaborator, "Cancer Trials Ireland" with 1 trials as a collaborator, "ETOP IBCSG Partners Foundation" with 1 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator and "Spanish Breast Cancer Research Group (GEICAM)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "MediOnko-Institut GbR" are "Breast Neoplasms" (1 trials), "HER2-negative Breast Cancer" (1 trials), "Malignant Haematological Tumour" (1 trials), "Primary or Secondary Prophylactic Treatment" (1 trials) and "Solid Tumour" (1 trials). Many other conditions were trialed in "MediOnko-Institut GbR" in a lesser frequency.

Most popular intervention types in "MediOnko-Institut GbR" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Capecitabine" (1 trials), "Carboplatin" (1 trials), "Cisplatin" (1 trials), "Palbociclib + endocrine therapy" (1 trials) and "Sacituzumab govitecan" (1 trials). Other intervention names were less common.

The vast majority of trials in "MediOnko-Institut GbR" are 3 trials for "All" genders.

Currently, there are NaN active trials in "MediOnko-Institut GbR". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in MediOnko-Institut GbR, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in MediOnko-Institut GbR, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".